Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies.

MLA

Bea, Sungho, et al. “Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies.” Yonsei Medical Journal, vol. 65, no. 2, Feb. 2024, pp. 120–28. EBSCOhost, https://doi.org/10.3349/ymj.2023.0207.

APA

Bea, S., Yoon, D., Jeong, H. E., Jung, J., Park, S.-M., Jeon, J., Ye, Y.-M., Lee, J.-H., & Shin, J.-Y. (2024). Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies. Yonsei Medical Journal, 65(2), 120–128. https://doi.org/10.3349/ymj.2023.0207

Chicago

Bea, Sungho, Dongwon Yoon, Han Eol Jeong, Juhong Jung, Seung-Mok Park, Juhee Jeon, Young-Min Ye, Jae-Hyun Lee, and Ju-Young Shin. 2024. “Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies.” Yonsei Medical Journal 65 (2): 120–28. doi:10.3349/ymj.2023.0207.